Naveen Pemmaraju: Intersection of neurosurgery and leukemia from two Johns Hopkins alums
Naveen Pemmaraju shared on X:
“Excellent discussion together today intersection of neurosurgery Shaan M. Raza and leukemia from two Johns Hopkins alums on an Osler Friday at MD Anderson Cancer Center.
‘Glioblastoma and acute myeloid leukemia: malignancies with striking similarities‘
Authors: Eric Goethe, Bing Z. Carter, Ganesh Rao, Naveen Pemmaraju.”
Source: Naveen Pemmaraju/X
Naveen Pemmaraju is a Professor and Director of BPDCN Program at the Department of Leukemia at the University of Texas MD Anderson Cancer Center (MDACC) and Executive Director of MDACC Network. He is also the Leukemia Hematology/Oncology Course Director.
His research work has been focused on improving outcomes and developing novel therapies for patients with rare, and ultra-rare, myeloid malignancies; including adolescents, young adults, and older adult patients with Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN), MPN and AML.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023